Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VSH✓SelectedUSD · VSHGSK vs VSH performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs VSH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+57.5%
VSH return
+19.7%
Excess return
+37.7%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioVSHExcessAlpha
1D-2.3%-0.1%-2.2%-2.3%
7D-3.0%-5.4%+2.4%-3.0%
30D+0.4%-8.5%+8.9%+0.3%
3M-1.2%-28.5%+27.3%-0.8%
6M+0.9%-31.6%+32.5%0.0%
YTD+4.0%+76.8%-72.8%-5.1%
1Y+7.3%+104.0%-96.7%-3.3%
All+57.5%+19.7%+37.7%+42.5%

Cumulative growth

Daily Returns

Daily percentage return beside VSH.

Daily Out/Under-Performance

Portfolio return minus VSH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded VSH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling